Page last updated: 2024-11-04

streptonigrin and Prostatic Neoplasms, Castration-Resistant

streptonigrin has been researched along with Prostatic Neoplasms, Castration-Resistant in 1 studies

Prostatic Neoplasms, Castration-Resistant: Tumors or cancer of the PROSTATE which can grow in the presence of low or residual amount of androgen hormones such as TESTOSTERONE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Takayama, T1
Sugiyama, T1
Furuse, H1
Yajima, T1
Suzuki, T1
Kai, F1
Nagata, M1
Otsuka, A1
Ishii, Y1
Ozono, S1

Other Studies

1 other study available for streptonigrin and Prostatic Neoplasms, Castration-Resistant

ArticleYear
[Salvage therapy for castration-refractory prostate cancer resistant to docetaxel].
    Nihon Hinyokika Gakkai zasshi. The japanese journal of urology, 2013, Volume: 104, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Clinical Trials

2013